A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
Authors
Keywords
-
Journal
DARU-Journal of Pharmaceutical Sciences
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-02
DOI
10.1007/s40199-022-00446-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- COVID-19 vaccines: where we stand and challenges ahead
- (2021) Guido Forni et al. CELL DEATH AND DIFFERENTIATION
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- Antibody response to SARS-CoV-2 infection in humans: A systematic review
- (2021) Nathan Post et al. PLoS One
- SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study
- (2021) Hossein Lanjanian et al. Scientific Reports
- Covid-19: Moderna plans booster doses to counter variants
- (2021) Janice Hopkins Tanne BMJ-British Medical Journal
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
- (2021) Saman Saadat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- SARS-CoV-2 variants and ending the COVID-19 pandemic
- (2021) Arnaud Fontanet et al. LANCET
- Sputnik V COVID-19 vaccine candidate appears safe and effective
- (2021) Ian Jones et al. LANCET
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- Covid-19: Where are we on vaccines and variants?
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
- (2021) Linde Schoenmaker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
- (2021) Salim S Abdool Karim LANCET
- Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
- (2021) Zhenyu He et al. LANCET
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
- (2021) Victoria Jane Hall et al. LANCET
- Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
- (2021) Shilong Yang et al. LANCET INFECTIOUS DISEASES
- What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine
- (2021) Smriti Mallapaty et al. NATURE
- Five reasons why COVID herd immunity is probably impossible
- (2021) Christie Aschwanden NATURE
- Covid-19: What do we know about Sputnik V and other Russian vaccines?
- (2021) Chris Baraniuk BMJ-British Medical Journal
- What do we know about China’s covid-19 vaccines?
- (2021) Chris Baraniuk BMJ-British Medical Journal
- A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
- (2021) Yingzhu Li et al. ACS Central Science
- Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
- (2021) Thai Thanh Hoang Thi et al. Vaccines
- Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
- (2021) André C. Ferreira et al. Cell Death Discovery
- From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
- (2021) Emily H. Pilkington et al. Acta Biomaterialia
- THE MOST RECENT SARS-CoV-2 MUTATIONS AND THEIR SUBSEQUENT VIRAL VARIANTS
- (2021) Begum Cosar et al. CYTOKINE & GROWTH FACTOR REVIEWS
- COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
- (2021) Philippe Buchy et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID‐2019) in 23 countries
- (2021) Lutfiye Karcioglu Batur et al. JOURNAL OF MEDICAL VIROLOGY
- The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19
- (2021) Ann M. Navar et al. PLoS One
- SARS-CoV-2 and pancreas: a potential pathological interaction?
- (2021) Shirin Geravandi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19
- (2021) Mariana Avendaño-Félix et al. VIRAL IMMUNOLOGY
- SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
- (2021) Michael J. Peluso et al. Science Advances
- Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
- (2021) Zhangkai Jason Cheng et al. Vaccines
- Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
- (2021) Jayanthi Shastri et al. Frontiers in Medicine
- Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
- (2021) Thibault Fiolet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study
- (2021) Asghar Abdoli et al. REVIEWS IN MEDICAL VIROLOGY
- The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
- (2021) Fei Chen et al. Frontiers in Cellular and Infection Microbiology
- Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice
- (2021) Moustafa T. Mabrouk et al. Science Advances
- Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility
- (2021) Anissa Viveiros et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
- (2020) Qing Cao et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
- (2020) Jiabao Xu et al. Viruses-Basel
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
- (2020) Junxiong Pang et al. Journal of Clinical Medicine
- Will children reveal their secret? The coronavirus dilemma
- (2020) Luca Cristiani et al. EUROPEAN RESPIRATORY JOURNAL
- Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
- (2020) Mona Fani et al. Future Virology
- Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
- (2020) Hisashi Kai et al. HYPERTENSION RESEARCH
- Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19
- (2020) Guoping Li et al. JOURNAL OF AUTOIMMUNITY
- The COVID-19 vaccine development landscape
- (2020) Tung Thanh Le et al. NATURE REVIEWS DRUG DISCOVERY
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 in the lung airways is lower in children compared to adults and increases due to smoking and COPD
- (2020) Narjes Saheb Sharif-Askari et al. Molecular Therapy-Methods & Clinical Development
- COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
- (2020) Elena Ciaglia et al. Frontiers in Pediatrics
- A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
- (2020) Neeltje van Doremalen et al. Science Advances
- Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
- (2020) Hsin-I Shih et al. Biomedical Journal
- The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
- (2020) Jieliang Wang et al. AAPS PHARMSCITECH
- Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation
- (2020) Jiawei Chen et al. AGING CELL
- Effects of host genetic variations on response to, susceptibility and severity of respiratory infections
- (2020) Soudeh Ghafouri-Fard et al. BIOMEDICINE & PHARMACOTHERAPY
- New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
- (2020) Yuan Hou et al. BMC Medicine
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- COVID-19, SARS and MERS: are they closely related?
- (2020) N. Petrosillo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Emerging vaccine delivery systems for COVID-19
- (2020) Nigel Theobald DRUG DISCOVERY TODAY
- Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
- (2020) Mohamed Boudjelal et al. Expert Opinion on Drug Discovery
- The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
- (2020) Inna G. Ovsyannikova et al. IMMUNOLOGICAL REVIEWS
- Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
- (2020) Giovanni A. Rossi et al. INFECTION
- Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19
- (2020) Moussa Sehailia et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Sex and gender differences in the outcome of patients with COVID‐19
- (2020) Shahab Falahi et al. JOURNAL OF MEDICAL VIROLOGY
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Immune-mediated approaches against COVID-19
- (2020) Helena F. Florindo et al. Nature Nanotechnology
- COVID-19 Vaccine: A comprehensive status report
- (2020) Simran Preet Kaur et al. VIRUS RESEARCH
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Developing a low-cost and accessible COVID-19 vaccine for global health
- (2020) Peter J. Hotez et al. PLoS Neglected Tropical Diseases
- The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention
- (2020) Hayat Ouassou et al. Journal of Immunology Research
- Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study
- (2020) Pedro Baqui et al. Lancet Global Health
- Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
- (2020) Vibhuti Kumar Shah et al. Frontiers in Immunology
- Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
- (2020) Chaofu Wang et al. EBioMedicine
- An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes?
- (2020) Parisa Maleki Dana et al. Prehospital and Disaster Medicine
- SARS-CoV-2 seroprevalence among parturient women in Philadelphia
- (2020) Dustin D. Flannery et al. Science Immunology
- Age and Location in Severity of COVID‐19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
- (2020) Robert Root‐Bernstein BIOESSAYS
- Vaccines for COVID‐19
- (2020) J. S. Tregoning et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- A Case of Early Re-infection with SARS-CoV-2
- (2020) Derek Larson et al. CLINICAL INFECTIOUS DISEASES
- Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2
- (2020) Vivek Gupta et al. CLINICAL INFECTIOUS DISEASES
- Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
- (2020) Kelvin Kai-Wang To et al. CLINICAL INFECTIOUS DISEASES
- Deciphering Vaccines for COVID-19: where do we stand today?
- (2020) Tushar Baviskar et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Genomic evidence for reinfection with SARS-CoV-2: a case study
- (2020) Richard L Tillett et al. LANCET INFECTIOUS DISEASES
- Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
- (2020) Nina Marí G.P. de Queiroz et al. MICROBES AND INFECTION
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development
- (2020) Jubeda Begum et al. Transboundary and Emerging Diseases
- Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
- (2020) Ricardo Palacios et al. Trials
- A comparative overview of COVID-19, MERS and SARS: Review article
- (2020) Jie Liu et al. International Journal of Surgery
- Virology, transmission, and pathogenesis of SARS-CoV-2
- (2020) Muge Cevik et al. BMJ-British Medical Journal
- Sex differences in severity and mortality from COVID-19: are males more vulnerable?
- (2020) Ajay Pradhan et al. Biology of Sex Differences
- A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
- (2020) Omna Sharma et al. Frontiers in Immunology
- From SARS to COVID-19: What lessons have we learned?
- (2020) Qin Liu et al. Journal of Infection and Public Health
- Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2
- (2020) Gabriel N. A. Rego et al. Vaccines
- Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
- (2020) Laith J Abu-Raddad et al. CLINICAL INFECTIOUS DISEASES
- Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
- (2020) Jee-Soo Lee et al. CLINICAL INFECTIOUS DISEASES
- Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients
- (2020) Ahmed Saleh et al. IMMUNOLOGICAL INVESTIGATIONS
- Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review
- (2020) Nidhi Chauhan et al. JOURNAL OF MEDICAL VIROLOGY
- ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
- (2020) HariOm Singh et al. MICROBIAL PATHOGENESIS
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical manifestations of COVID-19 in the general population: systematic review
- (2020) Rodrigo da Rosa Mesquita et al. WIENER KLINISCHE WOCHENSCHRIFT
- Platforms Exploited for SARS-CoV-2 Vaccine Development
- (2020) Shilu Mathew et al. Vaccines
- Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
- (2020) Francesca Salamanna et al. Frontiers in Medicine
- Correction to: Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
- (2020) Eriko Padron-Regalado Infectious Diseases and Therapy
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- DNA vaccines against COVID-19: Perspectives and challenges
- (2020) Marcelle Moura Silveira et al. LIFE SCIENCES
- A case of SARS-CoV-2 reinfection in Ecuador
- (2020) Belén Prado-Vivar et al. LANCET INFECTIOUS DISEASES
- Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene
- (2019) Céline Bouquet et al. JAMA Ophthalmology
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- (2019) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
- (2019) Naif Khalaf Alharbi et al. Scientific Reports
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2017) Rudragouda Channappanavar et al. JOURNAL OF IMMUNOLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Sex-based differences in immune function and responses to vaccination
- (2015) S. L. Klein et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
- (2014) L. Du et al. JOURNAL OF IMMUNOLOGY
- Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination
- (2013) D. Furman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
- (2011) Ye V. Liu et al. VACCINE
- SARS vaccines: where are we?
- (2009) Rachel L Roper et al. Expert Review of Vaccines
- Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
- (2008) R. H. See et al. JOURNAL OF GENERAL VIROLOGY
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
- (2008) Julie E. Martin et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started